
    
      This is a randomized, placebo controlled, multicenter study with parallel groups in order to
      evaluate the efficacy and safety of ulipristal acetate in female subjects with anemia
      associated with uterine leiomyomas. The objective of this study is to determine if daily
      ulipristal acetate with iron is more effective than iron alone.
    
  